The dearth of minority biomedical research professionals stems from the paucity of minority undergraduate students who are academically competitive candidates for graduate school; and, from the perception, even among well-qualified minority students, that the research community does not welcome minority participation. To remedy these problems, we will create a coherent, coordinated series of activities to support and encourage minority students academically and financially from the freshman undergraduate year through the second year of graduate school. Academic excellence will be cultivated in young undergraduates through a challenging, structured academic program of supplemental course work in chemistry and calculus, the gate-keepers to success in biology studies, while more advanced students will have their academic skills stimulated and honed through a series of coordinated academic enrichment activities. Beginning minority graduate students will be encouraged to persevere in attaining research careers by providing them with academic, financial, and personal support in the first two years of graduate school; a time during which many talented students become discouraged and leave graduate school due to lack of such support. Because students learn best by doing, and because student interest in research careers in kindled through laboratory work, student involvement in biomedical research will be a key program element at each level. We will create investigative partnerships between research faculty and minority students; such intensive interactions will develop the students' investigative skills, demonstrate that research is a viable career option, and will increase the number of non-minority faculty who can serve as productive mentors for minority students.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Education Projects (R25)
Project #
5R25GM056765-03
Application #
6151190
Study Section
Special Emphasis Panel (ZGM1-MBRS-9 (01))
Project Start
1998-02-01
Project End
2002-01-31
Budget Start
2000-02-01
Budget End
2001-01-31
Support Year
3
Fiscal Year
2000
Total Cost
$441,891
Indirect Cost
Name
University of California Davis
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Rincón, Esther; Rocha-Gregg, Briana L; Collins, Sean R (2018) A map of gene expression in neutrophil-like cell lines. BMC Genomics 19:573
Jiang, Guochun; Nguyen, Don; Archin, Nancie M et al. (2018) HIV latency is reversed by ACSS2-driven histone crotonylation. J Clin Invest 128:1190-1198
Finno, Carrie J; Bordbari, Matthew H; Gianino, Giuliana et al. (2018) An innate immune response and altered nuclear receptor activation defines the spinal cord transcriptome during alpha-tocopherol deficiency in Ttpa-null mice. Free Radic Biol Med 120:289-302
Liu, Chengfei; Armstrong, Cameron M; Lou, Wei et al. (2017) Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer. Mol Cancer Ther 16:1521-1530
Panorgias, Athanasios; Tillman, Megan; Sutter, Erich E et al. (2017) Senescent Changes and Topography of the Dark-Adapted Multifocal Electroretinogram. Invest Ophthalmol Vis Sci 58:1323-1329
Schwartzer, Jared J; Careaga, Milo; Coburn, Morgan A et al. (2017) Behavioral impact of maternal allergic-asthma in two genetically distinct mouse strains. Brain Behav Immun 63:99-107
Wu, Jun; Vilarino, Marcela; Suzuki, Keiichiro et al. (2017) CRISPR-Cas9 mediated one-step disabling of pancreatogenesis in pigs. Sci Rep 7:10487
White, Pamela M; Pietri, Jose E; Debec, Alain et al. (2017) Mechanisms of Horizontal Cell-to-Cell Transfer of Wolbachia spp. in Drosophila melanogaster. Appl Environ Microbiol 83:
De Jesus, Nicole M; Wang, Lianguo; Lai, Johnny et al. (2017) Antiarrhythmic effects of interleukin 1 inhibition after myocardial infarction. Heart Rhythm 14:727-736
Liu, Chengfei; Armstrong, Cameron M; Lou, Wei et al. (2017) Inhibition of AKR1C3 Activation Overcomes Resistance to Abiraterone in Advanced Prostate Cancer. Mol Cancer Ther 16:35-44

Showing the most recent 10 out of 62 publications